Archive

The Gauteng hospital overcrowding crisis deepens as MEC Nomantu Nkomo-Ralehoko rejects claims, blames patients, and bars journalists.

Bogus doctors remain a serious risk, says the HPCSA, as arrests rise and patients are urged to verify practitioners on the online register.

Sizwe Hosmed’s curatorship intensifies as the CMS alleges R522m in duplicate claims, stale payouts and credit card misuse.

Medical aid tax credits may be withdrawn from 2026. Analysis warns of medical aid membership losses and rising public-sector pressure.

Gauteng health turmoil as MEC Nomantu Nkomo-Ralehoko backs Lesiba Malotana despite SIU flags and fresh questions over hospital beds.

Sizwe Hosmed Curatorship is under scrutiny as curator Lebogang Mpakati defends private legal matters and outlines steps to restore solvency.

Eli Lilly has forecast 2026 profit and revenue above Wall Street expectations, reinforcing how fast the obesity market is reshaping Big Pharma growth plans. The recent Eli Lilly 2026 Guidance reflects the company’s confidence in strong future performance. The company also beat estimates for fourth-quarter earnings, helped by strong demand for its injectable weight-loss and […]

South Africa’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover fewer than a quarter of the target population. Deliveries are underway and will continue through April. Rollout will begin immediately after delivery, with an initial two-year implementation plan.

As National Pregnancy Week runs from 3-7 February, the South African Society of Psychiatrists (Sasop) is calling on healthcare providers and expectant mothers to treat perinatal mental health symptoms in pregnancy as urgent medical issues. The society says between 16% and 50% of women in South Africa experience depression or anxiety during pregnancy. It adds […]

Discover how healthcare investment drives growth, linking public health to stronger GDP performance in emerging markets.

Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure.